References
- Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, et al.. Diagnosis and management of acute myeloidleukemia in adults: recommendations from an international expert panel, onbehalf of the European LeukemiaNet. Blood 2010;115:453–74.
- Ryningen A, Stapnes C, Paulsen K, Lassalle P, Gjertsen BT, Bruserud Ø. In vivo biologicaleffects of ATRA in the treatment of AML. Exp Opin Investig Drugs 2008;17:1623–33.
- Bruserud Ø, Stapnes C, Tronstad KJ, Ryningen A, Anensen N, Gjertsen B. Protein lysine acetylation in normal and leukaemichaematopoiesis: HDACs as possible therapeutic targets in adult AML. ExpOpin The Targets 2006;10:51–68.
- Hatfield KJ, Olsnes AM, Gjertsen BT, Bruserud Ø. Antiangiogenic therapy in acute myelogenousleukemia: targeting of vascular endothelial growth factor and interleukin8 as possible antileukemic strategies. Curr CancerDrug Targets 2005;5:229–48.
- Al-Mawali A, Gillis D, Lewis I. The role of multiparameter flow cytometryfor detection of minimal residual disease in acute myeloid leukemia. AmJ Clin Pathol 2009;131:16–26.
- Steinbach D, Schramm A, Eggert A, Onda M, Dawczynski K, Rump A, et al.. Identification of a set of seven genesfor the monitoring of minimal residual disease in pediatric acute myeloidleukemia. Clin Cancer Res 2006;12:2434–41.
- Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C, et al.. Endocan or endothelial cell specificmolecule-1 (ESM-1): a potential novel endothelial cell marker and a new targetfor cancer therapy. Biochim Biophys Acta 2006;1765:25–37.
- Bechard D, Meignin V, Scherpereel A, Oudin S, Kervoaze G, Bertheau P, et al.. Characterization of the secreted formof endothelial-cell-specific molecule 1 by specific monoclonal antibodies. JVasc Res 2000;37:417–25.
- Dallett M, O’Hagan KA, Koyler HA, Mills KI. Identification of gene networks associatedwith acute myeloid leukemia by comparative molecular methylation and expressingprofiling. Biomark Cancer 2010;2:43–5.
- Hatfield K, Øyan AM, Ersvaer E, Kalland KH, Lassalle P, Gjertsen BT, et al.. Primary human acute myeloid leukaemiacells increase the proliferation of microvascular endothelial cells throughthe release of soluble mediators. Br J Haematol 2009;44:53–68.
- Ryningen A, Stapnes C, Lassalle P, Corbascio M, Gjertsen BT, Bruserud Ø. A subset of patients with high-risk acutemyelogenous leukemia shows improved peripheral blood cell counts when treatedwith the combination of valproic acid, theophylline and all-trans retinoicacid. Leuk Res 2009;33:779–87.
- Bruserud Ø, Halstensen A, Peen E, Solberg CO. Serum levels of adhesion molecules and cytokinesin patients with acute leukaemia. Leuk Lymphoma 1996;23:423–30.
- Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T, et al.. Endocan, a new endothelial marker inhuman sepsis. Crit Care Med 2006;34:532–7.